tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TARA Stock Latest News

Protara Therapeutics files to sell 21.69M shares of common stock for holders
The FlyProtara Therapeutics files to sell 21.69M shares of common stock for holders
5d ago
TARA
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
5d ago
TARA
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
PremiumThe Fly
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
6d ago
TARA
Protara Therapeutics price target raised to $30 from $26 at Oppenheimer
PremiumThe Fly
Protara Therapeutics price target raised to $30 from $26 at Oppenheimer
16d ago
TARA
Protara Therapeutics Launches $45M Private Placement Drive
PremiumCompany Announcements
Protara Therapeutics Launches $45M Private Placement Drive
1M ago
8K
TARA
Protara Therapeutics announces $45M private placement financing
PremiumThe FlyProtara Therapeutics announces $45M private placement financing
1M ago
TARA
Protara Therapeutics announces three-month data from TARA-002 program
PremiumThe Fly
Protara Therapeutics announces three-month data from TARA-002 program
1M ago
TARA
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
PremiumPress Releases
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
1M ago
TARA
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
PremiumPress Releases
Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
1M ago
TARA
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
PremiumPress Releases
Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
1M ago
TARA
Protara announces alignment with FDA on path forward for IV Choline Chloride
PremiumThe Fly
Protara announces alignment with FDA on path forward for IV Choline Chloride
1M ago
TARA
Protara Therapeutics CMO Resigns, Interim Successor Named
PremiumCompany Announcements
Protara Therapeutics CMO Resigns, Interim Successor Named
2M ago
8K
TARA
Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress ReleasesProtara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
TARA
Protara Therapeutics expects cash to fud operations into 2Q25
PremiumThe Fly
Protara Therapeutics expects cash to fud operations into 2Q25
2M ago
TARA
Protara Therapeutics reports Q4 EPS (90c), consensus (92c)
PremiumThe Fly
Protara Therapeutics reports Q4 EPS (90c), consensus (92c)
2M ago
TARA
Is TARA a Buy, Before Earnings?
PremiumPre-Earnings
Is TARA a Buy, Before Earnings?
2M ago
TARA
Protara Therapeutics to Participate in Upcoming Investor Conferences
PremiumPress Releases
Protara Therapeutics to Participate in Upcoming Investor Conferences
3M ago
TARA
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
PremiumPress Releases
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
5M ago
TARA
Protara announces additional results from Phase 1a dose-escalation of TARA-002
PremiumThe Fly
Protara announces additional results from Phase 1a dose-escalation of TARA-002
5M ago
TARA
Protara Therapeutics files $300M mixed securities shelf
PremiumThe FlyProtara Therapeutics files $300M mixed securities shelf
6M ago
TARA
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
PremiumPress Releases
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
6M ago
TARA
Protara Therapeutics reports Q3 EPS (87c), consensus (98c)
PremiumThe Fly
Protara Therapeutics reports Q3 EPS (87c), consensus (98c)
6M ago
TARA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >